Galderma Investigational site (8161)

Surrey, British Columbia V3V 0C6

0 studies enrolling now · 3 studies all time

What they study most

Acne Vulgaris, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed
• Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris — Completed